| Variable (Diabetic Range) |
Thiamine Treatment |
Placebo |
| |
Baseline |
Therapy |
Washout |
Baseline |
Therapy |
Washout |
| S VCAM1 (ng/ml) |
588±267 |
554 ± 224 |
481± 192d, g
P’<0.05;
P”<0.05 |
648±255 |
608 ± 178 |
600 ± 232 |
| VWF (U/ml) |
0.67 (0.07 – 5.18) |
0.48 (0.01 – 2.95) |
0.51 (0.071 – 1.97) |
0.48 (0.01 – 4.35) |
0.48 (0.01 – 4.41) |
0.59 (0.01 – 1.61) |
| P AI1 (ng/ml) |
5.40±1.017 |
5.36±0.99 |
5.35±1.26 |
5.91±1.688 |
6.14 ± 1.44 |
6. 84 ± 1.36 |
| Plasma thiols nmol/μl |
3.91±0.723 |
3.71 ± 0.72 |
3.69 ± 0.64 |
4.15 ± 0.86 |
4.01 ± 0.89 |
3.97 ± 0.85 |
| Protein kinase C pg/μg |
60 ± 15.30 |
30.26 ± 19.37 |
37.98 ± 18.66 |
76.65 ± 56.22 |
77.75 ±58.29 |
98.67 ±76.48 |
|
